China Money Network
Login
Join

Tasley Pharma Leads $20M Round In Chinese Innovative Drug Developer PegBio

  • July 17, 2017 — 13:36 CST

This Data Is Locked!

This area is available only to Subscribers.

Tasley Pharma, a pharmaceutical company backed by Shanghai Stock Exchange-listed Tasley Holding Group, has led a US$20 million series E round in PegBio Co. Ltd.,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: